Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
The R&D CI analyst will provide competitive intelligence analyses and insights to support pipeline innovation, clinical development and decision-making for projects in early research through Phase II CRMDR.
The analyst will work with the CRDI Director and external consultants to guide portfolio prioritization, participate in conference coverage, and transform diverse scientific and business data into actionable inputs for Boehringer Ingelheim partners.
The R&D CI analyst will provide competitive intelligence analysis and insights to support pipeline innovation, clinical development and decision-making for projects in early research through Phase II clinical development in Cardio-Renal-Metabolic Disease Research (CRMDR).
The R&D CI Analyst should have broad knowledge of the pharmaceutical R&D process and demonstrated expertise in gathering intelligence from structured and unstructured sources, synthesizing findings into audience-friendly deliverables, generating actionable insights, and communicating them to Boehringer Ingelheim partners in a timely manner. Prior work or research experience in cardiovascular, renal, liver, metabolic, or autoimmune diseases is required. Experience applying AI-enabled tools, large language models, or advanced analytics to literature, clinical trial, patent, or competitive intelligence workflows is preferred. The Analyst is also expected to be able to work in cross functional teams, have good communication and influencing skills.
Required: advanced degree PhD/PharmD/MD or MS/MPH. Cardiovascular/Renal/Metabolic disease expertise.
Preferred: patent/licensing knowledge, AI/LLM experience.